This study evaluated the biological correlates and psychometrics of the Biber Figure Learning Test (BFLT), a visuospatial serial figure learning test, for use in detecting cognitive impairment in older adults. Non-demented individuals (n=322, 72±7, 41% female) from the Vanderbilt Memory & Aging Project completed a comprehensive neuropsychological protocol. Adjusted regression models related BFLT indices to structural brain MRI and cerebrospinal fluid markers (CSF) of brain health. Psychometric properties were examined, including construct validity and regressionbased normative data. Lower BFLT performance related to smaller medial temporal lobe volumes and higher CSF tau concentrations. BFLT indices were most strongly correlated with other measures of verbal and non-verbal memory measures and executive functioning. The BFLT comprehensively assesses all aspects of visuospatial learning and memory and is sensitive to markers of unhealthy brain aging. Enhanced normative data enriches the clinical utility of this visual serial figure-learning test for use with older adults.
Introduction
Alzheimer's disease (AD) is a major public health issue, and early diagnosis is critical to managing disease burden. As such, neuropsychological assessment, specifically episodic learning and memory, is an integral component for early and accurate diagnosis of AD (Karantzoulis & Galvin, 2011) . Clinically, AD is often characterized by an insidious decline in episodic memory, particularly in the early phases of illness. Serial verbal list-learning tests (e.g., Brandt, 2001; Delis, Kramer, Kaplan, & Ober, 2000) have demonstrated great utility in early detection of AD because they assess key constructs underlying memory and learning, including encoding or rate of acquisition, retrieval, and susceptibility to proactive and retroactive interference (Albert et al., 2011) . Examples of such verbal supraspan tests include the California Verbal Learning Test-Second Edition (CVLT-II; Delis et al., 2000) , the Rey Auditory Verbal Learning Test (Tierney et al., 1994) , and the Hopkins Verbal Learning Test-Revised (Brandt, 2001) .
Surprisingly, a non-verbal analogue to these verbal list-learning tests is lacking given the number of commonly used tools to assess aspects of visual encoding, retrieval, and memory. While each measure is valuable in assessing some aspects of visual learning and memory, no single tool reflects the full range of episodic memory constructs that are essential to define in clinical practice. For example, common visual measures, such as Rey-Osterrieth Complex Figure Test (Osterrieth, 1944; Rey, 1941) , WMS Visual Reproduction (Wechsler, 2009), or Benton Visual Retention Test (BVRT; Sivan, 1992) , assess memory using a single exposure or learning trial, limiting measurement of learning (acquisition) . While tests such as the Brief Visuospatial Memory Test-Revised (Benedict, Schretlen, Groninger, Dobraski, & Shpritz, 1996) and the Visual Spatial Learning Test (Malec, Ivnik, & Hinkeldey, 1991) include presentation of material over several learning trials, neither tool assesses vulnerability to proactive or retroactive interference through introduction of a distractor trial. Thus, while several visual learning and memory tools are available for clinical implementation, their varied methodologies limit more detailed assessment of well-known constructs underlying episodic memory, including encoding, retrieval, recognition, and susceptibility to interference. Further, the existing paradigms preclude direct comparison with existing verbal supraspan tests.
The Biber Figure Learning Test (BFLT) is a visuospatial serial figure learning test designed to assess key components underlying episodic memory (Glosser, Goodglass, & Biber, 1989) . It was modelled after supraspan tests (Delis, Kramer, Kaplan, & Ober, 1987; Delis et al., 2000) and Rey's visuospatial task (Rey, 1968) , and was originally developed as a 10-item memory test (Glosser et al., 1989) . The BFLT (extended; Glosser, Cole, Khatri, DellaPietra, & Kaplan, 2002) is comprised of five immediate free recall learning trials of 15 non-familiar geometric shapes of moderate visual complexity, an interference condition that presents a new list of 15 items (Distractor Trial), short and long delay free recall trials for the original 15 items, and a recognition trial that includes the original items, interference items, and new test items.
The BFLT offers several advantages over other available visual memory tools.
First, it is a visuospatial analogue to verbal list-learning tasks with indices capturing encoding/rate of acquisition, retrieval, susceptibility to proactive and retroactive interference, and recognition test performance. Thus, when used together, both tools provide parallel information to inform the potential presence of modality-specific memory impairment. Second, the BFLT has an alternate test form for repeat administration needs. Third, the BFLT includes an abbreviated 10-item version to accommodate patients suspected of more compromised neuropsychological function, such as dementia (Glosser et al., 2002; Glosser et al., 1989) . Collectively, the BFLT provides an opportunity to comprehensively assess specific visual episodic modalities using a format consistent with a verbal serial list-learning paradigm, making the BFLT potentially more useful than many widely used visual memory tools.
Despite the BFLT's potential clinical utility, the test has not been widely used.
Foremost, the validity of this visuospatial memory test is not well delineated.
Establishing a link between BFLT indices and markers of unhealthy brain aging, including AD, such as amyloid, neurodegeneration, and white matter disease is essential to demonstrating the utility and validity of this test in older adult populations.
Existing BFLT data have been restricted to individuals with epilepsy or non-AD amnestic syndromes implicating medial temporal lobe and subcortical-limbic pathways (Glosser et al., 1989) , particularly within the right hemisphere (Glosser et al., 2002) . Similarly, establishing evidence of convergent and discriminant validity with other neuropsychological measures is needed. Second, there is a lack of comprehensive normative data; existing normative data is restricted to a few dozen individuals and upper age bands (e.g., 40 to 79 years; Glosser et al., 1989) with minimal consideration of how important demographic variables, such as age, sex, education, and race/ethnicity (Norman, Evans, Miller, & Heaton, 2000) may confound performance.
Leveraging a community-based sample, this study has several objectives. First, we aim to examine the biological correlates of the BFLT, hypothesizing that BFLT indices would relate to markers of unhealthy brain aging including amyloid pathology (cerebrospinal fluid (CSF) amyloid beta42; Mandecka et al., 2016) , neurodegeneration (hippocampal volume on brain MRI, inferior lateral ventricle volume on brain MRI, and CSF tau; Mandecka et al., 2016; Murphy et al., 2010; Wolk & Dickerson, 2011) and white matter disease (white matter hyperintensities (WMH) on brain MRI and CSF neurofilament light; Lee et al., 2016; Zetterberg et al., 2016) . Second, we will test associations between the BFLT and other neuropsychological tests, hypothesizing BFLT indices will correlate most strongly with tests assessing verbal learning and memory (Benedict et al., 1996) and visuospatial and executive function (Jefferson et al., 2006) but not language (Meyers & Meyers, 1995) . Lastly, we provide regression-based normative data accounting for demographic variables that often confound cognitive performance including age, sex, race/ethnicity, and education (Glosser et al., 1989; Norman et al., 2000) . These efforts will enhance the BFLT's utilization as a more valuable tool in the assessment of visuospatial serial figure learning task in older adults.
Methods

Participants
Participant data were drawn from the Vanderbilt Memory & Aging Project (Jefferson et al., 2016) , a longitudinal observational study investigating vascular health and unhealthy brain aging. Participants were recruited through postal mailings, radio advertisements, newsletters, research distribution emails, community events, websites, and word-of-mouth. Inclusion required participants be age 60 years or older, speak English, have adequate auditory and visual acuity for testing purposes, and have a reliable study partner defined as someone the participant has known for a minimum of two years, with weekly contact, and knowledge of the participant's cognitive and functional abilities. At eligibility, participants underwent medical history and record review, clinical interview with the participant and their informant using the Clinical Dementia Rating (CDR; Morris, 1993) and Functional Activities Questionnaire (Pfeffer, Kurosaki, Harrah, Chance, & Filos, 1982) , and a comprehensive neuropsychological protocol assessing multiple cognitive systems. Collectively, this information was used by a consensus team to determine each participant's cognitive diagnosis, including:
1. Cognitively normal participants (NC): defined as (a) CDR=0 (no dementia), (b) no deficits in activities of daily living directly attributable to cognitive impairment, and (c) no evidence of neuropsychological impairment defined as standard scores falling within 1.5 standard deviations of the age-adjusted normative mean.
2. Early MCI: defined as (a) Clinical Dementia Rating (CDR)=0.5 (reflecting mild severity of impairment), (b) no deficits in activities of daily living attributable to cognitive issues, and (c) no neuropsychological impairment defined as standard scores falling within 1.5 standard deviations of the age-adjusted normative mean (Aisen et al., 2010) .
3. MCI: defined as (a) CDR=0 or 0.5 (reflecting mild severity of impairment), (b) relatively spared activities of daily living, (c) neuropsychological impairment within at least one cognitive domain (i.e., performances falling greater than 1.5 standard deviations outside the age-adjusted normative mean or premorbid level of functioning), (d) concern of a cognitive change by the participant, informant, or clinician, and (e) absence of a dementing syndrome (Albert et al., 2011) .
Participants were excluded for a diagnosis other than normal cognition, early MCI, or MCI, history of neurological disease (e.g., dementia, multiple sclerosis, stroke), heart failure, major psychiatric illness, head injury with loss of consciousness >5 minutes, and systemic or terminal illness that could affect the individual's ability to participate in follow-up examinations. Ultimately, this study enrolled 335 community-dwelling individuals age 60 to 92 years.
Neuropsychological Assessment
As part of the study enrollment visit, participants completed a neuropsychological protocol assessing multiple cognitive systems. Note, this protocol was different than what was used for eligibility determination and cognitive diagnosis at study entry. The Table 1 for a more detailed description of these indices and information regarding the remaining measures in the neuropsychological protocol.
Brain MRI
Participants were scanned at the Vanderbilt University Institute of Imaging Science on a 3T Philips Achieva system (Best, The Netherlands) with 8-channel SENSE reception (Pruessmann, Weiger, Scheidegger, & Boesiger, 1999) . T1-weighted MPRAGE (isotropic spatial resolution=1mm) images were post-processed for tissue volume quantification using an established Multi-Atlas Segmentation (Asman & Landman, 2012) . Specific regions of interest included hippocampal volume and inferior lateral ventricle volume measured within each hemisphere and then summed across hemispheres for a total volume. Intracranial volume was defined using voxel-based morphometry in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). T2-weighted fluid-attenuated inversion recovery (FLAIR) was acquired for quantification of WMH and post-processed using the Lesion Segmentation Tool toolbox for SPM8 (Schmidt et al., 2012) .
Cerebrospinal Fluid Acquisition
A subset of individuals (82 participants) completed an optional morning fasting lumbar puncture. CSF was collected with polypropylene syringes using a Sprotte 25gauge spinal needle in the L3/L4 or L4/L5 intervertebral lumbar space. Samples were immediately mixed and centrifuged, and supernatants were aliquoted in 0.5mL polypropylene tubes and stored at -80°C. Samples were analyzed in batch using commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) to determine the levels of Aβ1-42 (INNOTEST® β-AMYLOID(1-42)), total tau (INNOTEST® hTAU), and tau phosphorylated at threonine 181 (p-tau; INNOTEST® PHOSPHO-TAU(181P)). Neurofilament Light (NFL) was measured using a commercially available ELISA (Uman Diagnostics). Processing was completed by board certified laboratory technicians who were blinded to clinical information (Palmqvist et al., 2014) .
Intra-assay CVs were <10%.
Statistical Analysis
Descriptive statistics for participant characteristics including age, sex, race/ethnicity, education, mood (assessed with Geriatric Depression Scale (GDS) total score; Yesavage et al., 1983) , CSF levels, brain MRI variables, and neuropsychological performances (see Table 1 for a comprehensive list of measures) were calculated. To assess construct validity, linear regression related selected BFLT indices (Total Learning, Short Delay Recall, Long Delay Recall, Total Discrimination) to markers of unhealthy brain aging adjusting for age, sex, education, race/ethnicity, and diagnosis in the entire cohort. Specifically, we assessed amyloidosis (CSF AB42), neurodegeneration (CSF tau, CSF p-tau, hippocampal volume, inferior lateral ventricle volume), and white matter disease (WMH, CSF NFL). WMH values were log-transformed due to nonnormal distributions. Models analyzing brain volume outcomes additionally adjusted for intracranial volume. Convergent and discriminant validity were assessed in the NC subsample using Spearman's rank correlation coefficients to relate selected BFLT indices with other neuropsychological variables and GDS total score (see Table 1 for a comprehensive list of measures). Regression-based normative data of the above selected BFLT indices was generated from the NC subgroup using multiple regression analyses adjusting for age, sex, education, and race/ethnicity. The raw score on the selected BFLT indices were used as outcomes. Sex was coded as male=0, female=1 and race/ethnicity was coded as White/Non-Hispanic=0, Non-White/Hispanic=1. Age and education in years were treated as continuous variables. Multi-collinearity was assessed by calculating variance inflation factors (VIFs) and residuals plots were visually inspected for goodness of fit. Intercepts, beta-coefficients, and the root-meansquared error for each model were presented for calculation of a predicted BFLT performance value using the following equation (see Equation 1):
(1) Predicted score= β0 (intercept) + βage X age (actual age in years) + βsex X sex (0=male, 1=female) + βrace/ethnicity X race/ethnicity (0=White/Non-Hispanic, 1=Non-White/Hispanic) + βeducation X education (years of education completed).
To calculate a z-score normative value, the predicted score calculated in Equation 1 was used within the following equation (see Equation 2; Shirk et al., 2011): (2) z-score = (observed scorepredicted score)/root-mean-squared-error.
Significance was set a priori at p<0.05. All analyses were conducted using R 3.2.0 (www.r-project.org).
Results
Participant Characteristics
The entire cohort comprised 322 participants with an age range of 60 to 92 years (73±7) and an education range of 7 to 20 years (16±3). Approximately half (51%, n=174) of individuals had normal cognition, 41% were women and 87% self-declared as White/Non-Hispanic. Global cognition, as assessed by the Montreal Cognitive Assessment (MoCA), ranged 14 to 30 (25.4±3.3). Table 4 ).
White Matter Disease: None of the BFLT indices were related to WMH volume (all p-values>0.12; see Table 4 ).
BFLT Correlations with Other Cognitive Measures
Global Cognition: MoCA performance was moderately correlated with all BFLT indices (all p-values<0.001, see Table 5 ).
Verbal Learning & Memory:
CVLT-II Total Learning, Short Delay Free Recall, Long Delay Free Recall, and Recognition Total Discrimination correlated with all selected BFLT indices (p-values<0.001; see Table 5 ). CVLT-II Distractor Trial was correlated with most BFLT indices (p<0.02; see Table 5 ) but was unrelated to BFLT Recognition Total Discrimination (p=0.09; see Table 5 ).
Visuospatial Learning & Memory:
BVRT Total Score correlated with all selected BFLT indices (p-values<0.002; see Table 5 ).
Visuospatial Abilities: Wechsler Adult Intelligence Scale-IV (WAIS-IV; Wechsler, 2008 ) Block Design correlated with most BFLT indices (p-values<0.001) but not BFLT Distractor Trial (Trial B; p=0.08; see Table 5 ). Hooper Visual Organization Test (Hooper, 1983) performance was related to all selected BFLT indices (p-values<0.001).
See Mood: GDS was unrelated to all BFLT indices (all p-values>0.37). See Table 5 for details.
BFLT Regression-Based Normative Data
Review of VIF revealed no multicollinearity between predictor and demographic variables (all VIF<1.11). The residual plots against predicted values did not reveal any systematic patterns, suggesting sufficient goodness of fit. Means, intercepts, and regression coefficients are presented in Table 6 for transforming raw scores into 
Discussion
The BFLT is a visuospatial serial figure-learning test that allows for comprehensive assessment of visual learning and memory and offers advantages to existing visual memory tests. This study aimed to improve the clinical utility of the BFLT among older adults by demonstrating the test's psychometric properties, including validity. Specifically, BFLT performances were broadly related to CSF tau and medial temporal lobe brain volumes, but minimal associations with CSF amyloid or markers of white matter disease (WMH or CSF NFL) were observed. Furthermore, compared to other neuropsychological tests, BFLT indices correlated with measures of verbal learning and memory, information processing, executive functioning, and visuospatial performances, as expected. BFLT was also (unexpectedly) related to language tests.
To further maximize the measure's usefulness, regression-based normative data is provided with adjustments for common demographic confounds.
The current results suggest that performance on the BFLT is related to medial temporal lobe structures involved in successful learning and memory. These structures include the hippocampus and surrounding perirhinal areas critical for the formation of new memories (Fell et al., 2001) . These regions have been linked with performance on verbal supraspan episodic memory tests (Wolk & Dickerson, 2011) and existing visual memory tests (Buffalo, Reber, & Squire, 1998) . The current results are among the first to highlight the construct validity of the BFLT to measure integrity of learning and memory structures.
In addition to structural evidence of neurodegeneration, the BFLT was associated with CSF tau, another marker of neurodegeneration, but not amyloidosis or white matter disease. Early patterns of atrophy seen on brain MRI are most notable within the medial temporal lobe (Convit et al., 2000) , including the hippocampus (Fox et al., 1996) and inferior lateral ventricles (Thompson et al., 2004) because this region is the first to be affected by AD pathology. Tau deposition begins in the entorhinal cortex, spreading to the hippocampus and surrounding medial temporal regions (Braak & Braak, 1991; Duyckaerts, Delatour, & Potier, 2009 ), resulting in axonal loss and neurodegeneration.
Tau deposition levels and brain volume loss are thought to be closely related (Fjell et al., 2010) and represent disease or symptom severity (Blennow, 2004) . Additionally, tau correlates with objective cognitive performance (Samgard et al., 2010) , including episodic memory (Fjell et al., 2008) , often more closely than markers of amyloidosis (Brier et al., 2016) . Taken cumulatively, the BFLT may be an important tool to assess for underlying neurodegenerative disorders.
The stronger association between BFLT indices and regions within the left medial temporal lobe as compared to the right was somewhat unexpected given earlier work linking the right medial temporal lobe with BFLT performances in epilepsy or non-AD related amnestic syndromes (Glosser et al., 2002; Glosser et al., 1989) . However, this discrepant finding may be related to differing methodology given the previous results did not include any neuroimaging analyses and focused on clinical presentation of epilepsy patients. The current finding highlights the importance of left medial temporal lobe integrity for visual memory tasks, an observation supported by a functional MRI study linking activation in the left hippocampus to visual memory (Ranganath, Cohen, Dam, & D'Esposito, 2004) . Alternatively, the right hippocampus may be integral in encoding/recalling information regarding spatial navigation or location (Burgess, Maguire, & O'Keefe, 2002; Kesner, Bolland, & Dakis, 1993) , a component of visuospatial memory and processing that is less essential to successful BFLT performance. Notably, the current findings suggest bilateral hippocampal integrity for retrieval of visual information, consistent with a recent meta-analysis implicating both the right and left hippocampus in retrieval of visual information (Lepage, Habib, & Tulving, 1998) . The preferential association with the left hemisphere in encoding visual information provides additional evidence that individuals often utilize verbal strategies to encode visual material, even non-meaningful visual information, thus employing left hemisphere regions.
Surprisingly, there was a paucity of associations between BFLT indices and white matter disease. These null associations were surprising given the link between white matter disease and verbal memory, including supraspan paradigms analogous to the BFLT (Kennedy & Raz, 2009). Also, BFLT performance was related to measures of information processing speed and executive functioning, cognitive domains that are often closely correlated with WMH burden (Madden, Bennett, & Song, 2009; Prins et al., 2005) . The null findings could be due to the inclusion of cognitively normal participants in the analyses as well as the low prevalence of cardiovascular disease across the entire sample.
BFLT related to verbal memory and visuospatial performances as measured by other popular tools (Benton, 1974; Delis et al., 2000) . Similarly, BFLT correlated with executive function performances, an expected finding given the executive demands of the BFLT and existing support linking visuospatial abilities with executive skills. Prior research has suggested that executive functions, such as the capability to monitor and switch between the target and distractor set of stimuli and the ability to organize the geometric shapes into accurate designs, is important during visuospatial tasks (Jefferson et al., 2006; Libon et al., 1994) . Unexpectedly, BFLT was related to language performances possibly because individuals with more intact language abilities utilize verbal cues or assign common object descriptions to the BFLT design stimuli as a tool for successfully remembering design details (Schacter, Cooper, & Delaney, 1990) . This idea is supported by our finding that BFLT performance appeared preferentially related to left hemisphere medial temporal lobe functioning and suggesting that successful performance on BFLT indices relies on integrity of brain regions also important for language abilities.
Advancing age was noted to be related to poorer performance on all BFLT indices, consistent with previously research linking increasing age with declines in verbal memory (Gunning-Dixon & Raz, 2003; Norman et al., 2000) and visual retention (Coman et al., 1999) . Sex, race/ethnicity, and education were inconsistently related to the various BFLT indices, although results are aligned with previous research suggesting better cognitive performance is related to more years of education, female sex, and White/non-Hispanic ethnicity. Given these potential demographic confounds on task performance, the regression-based normative data provided here incorporate all of these demographic factors, allowing for more robust generation of normative data.
Additionally, the sample size of 174 well-characterized, cognitively normal, adults age 60 to 92 represents an improvement to the existing normative data, facilitating more widespread clinical use of the BFLT.
The current study has several strengths. First, the extensive phenotyping of cognitive status for all enrolled participants included a CDR interview with the participant and a reliable informant, medical record and health history review, comprehensive neuropsychological protocol, and consensus decision for diagnostic status by experienced clinicians. Second, the comprehensive neuropsychological protocol examined in the current methods (which was separate from the protocol used to diagnose and enroll participants as NC) encompassed multiple cognitive domains, permitting detailed comparisons between BFLT and other cognitive task performances.
Third, the normative sample size of the current study (n=174) and use of regression norms considering multiple demographic confounders enhances the one existing BFLT normative data report (Glosser et al., 2002) . Fourth, the correlation data with other common neuropsychological tests, including an analogous verbal supraspan test, also provide context for interpreting underlying BFLT impairments in a comprehensive clinical evaluation. Lastly, this study is the first linking the BFLT to biological markers of brain health to assess the measure's validity.
Despite these strengths, there are several limitations. First, aspects of the cohort could limit the generalizability to the findings. For example, the sample is predominantly White with a mean college education level. Similarly, the inclusion and exclusion criteria associated with enrollment into the Vanderbilt Memory & Aging Project, including minimal cardiovascular disease, may limit generalized applicability. Second, the current study includes a smaller sample size in comparison to previous normative research with other learning and memory tests (Fine, Kramer, Lui, Yaffe, & Study Of Osteoporotic Fractures Sof Research, 2012; Gallassi et al., 2014) . However, regression-based normative procedures require smaller samples sizes than traditional-based normative procedures (Oosterhuis, van der Ark, & Sijtsma, 2016) , and this study represents an initial and more comprehensive approach.
Overall, our findings provide novel information about the BFLT to enhance the clinical utility of this visuospatial serial figure learning test. The BFLT measures brain health and integrity through the assessment of multiple aspects of learning and memory, including learning or rate of acquisition, encoding or storage, retrieval, recognition, and freedom from interference. Results suggest the BFLT has good psychometric properties and relates to medial temporal lobe integrity. Regression-based normative data based upon age, sex, education, and race/ethnicity are provided to enhance clinical utility of this promising visuospatial memory test. Further work is needed linking BFLT performance to longitudinal change in markers of pathology. Kaplan, E., Goodglass, H., & Weintraub, S. (1983) . The Boston Naming Test (2nd ed.). Philadelphia, PA: Lea & Febiger.
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Global Cognition
Montreal Cognitive Assessment (Nasreddine et al., 2005) Measures global cognitive status 0-30
Episodic
Learning & Memory
Biber Figure Learning Test (BFLT; Glosser et al., 2002; Glosser et al., 1989) BFLT Total Learning (Trials 1-5) Assesses learning for a set of 15 geometric designs across 5 trials Figure Learning Test; CSF= cerebrospinal fluid; Aβ=amyloid beta; T-tau=total tau; p-tau=phosphorylated tau; NFL=neurofilament light; WMH=white matter hyperintensity (log-transformed); *significance threshold at p-value<0.05. 
